Hocking v Medical Board of Australia

In the case of Hocking v Medical Board of Australia, the dispute centred around the appellant's appeal against the respondent's decision to suspend his registration. The appellant argued that the tribunal had the power to set aside the decision to suspend his registration, and that the appropriate order was to set aside the decision and substitute a decision to take no further action in respect of the notification. The respondent contended that the tribunal only had the power to substitute a decision and not to set aside the decision.

The legal issue before the court was whether the tribunal had the power to set aside the decision to suspend the appellant's registration, or whether it was limited to substituting a decision. The court considered the relevant provisions of the National Law, including sections 199 and 202, and concluded that the tribunal did have the power to set aside a decision if it was necessary to give meaningful effect to the right of appeal. The court found that the tribunal had the power to substitute a decision, but also that it could set aside a decision if it was appropriate in the circumstances.

The court held that the tribunal did have the power to set aside the decision to suspend the appellant's registration, and that the appropriate order was to substitute a decision to impose a condition on the appellant's registration. The court found that the appellant's treatment of paediatric patients who have Perthes Disease with platelet rich plasma was not in the best interests of the patients and that it was necessary to impose a condition to protect the public. The court also found that the decision to suspend the appellant's registration was not appropriate in the circumstances and that it was sufficient to impose a condition on his registration.

The orders made by the court were that the decision to suspend the appellant's registration be set aside and that a decision be substituted to impose a condition on his registration prohibiting him from treating paediatric patients who have Perthes Disease with platelet rich plasma unless he does so under the supervision of a specialist orthopaedic surgeon approved by the respondent Board.